Trial intelligence / Profile preview

Insulin-loaded nano hydrogel in adults with type 2 diabetes

IRCT201412129626N4Phase 2Completed

Sponsor
Tabriz University of Medical Sciences
Start
Dec 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Blood glucose level and Insulin level. Started Dec 2014; status: completed.

02

Drugs

human insulin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on IRCT201412129626N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201412129626N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call